2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)

Eur Heart J. 2015 Nov 7;36(42):2921-2964. doi: 10.1093/eurheartj/ehv318. Epub 2015 Aug 29.
No abstract available

Keywords: Aetiology; Constrictive pericarditis; Diagnosis; Guidelines; Myopericarditis; Pericardial effusion; Pericardiocentesis; Pericarditis; Pericardium; Prognosis; Tamponade; Therapy.

Publication types

  • Practice Guideline

MeSH terms

  • Acute Disease
  • Age Factors
  • Anti-Inflammatory Agents / therapeutic use
  • Autoimmune Diseases / complications
  • Bacterial Infections / diagnosis
  • Bacterial Infections / therapy
  • Biomarkers / metabolism
  • Biopsy
  • Cardiac Catheterization
  • Cardiac Tamponade* / diagnosis
  • Cardiac Tamponade* / etiology
  • Cardiac Tamponade* / therapy
  • Chronic Disease
  • Drainage / methods
  • Echocardiography
  • Endoscopy
  • Heart Injuries / complications
  • Heart Neoplasms / diagnosis
  • Heart Neoplasms / etiology
  • Heart Neoplasms / therapy
  • Hospitalization
  • Humans
  • Kidney Failure, Chronic / complications
  • Magnetic Resonance Angiography
  • Multimodal Imaging / methods
  • Pericardial Effusion* / diagnosis
  • Pericardial Effusion* / etiology
  • Pericardial Effusion* / therapy
  • Pericardiocentesis / methods
  • Pericarditis* / diagnosis
  • Pericarditis* / etiology
  • Pericarditis* / therapy
  • Physical Examination
  • Positron-Emission Tomography
  • Postoperative Complications / etiology
  • Radiation Injuries / complications
  • Recurrence
  • Sex Factors
  • Syndrome
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Triage
  • Virus Diseases / diagnosis
  • Virus Diseases / therapy

Substances

  • Anti-Inflammatory Agents
  • Biomarkers